Excitatory Amino Acid Agents: Clinical Trials

2 trials for Excitatory Amino Acid Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Excitatory Amino Acid Agents: new trials by email Literature Review of Excitatory Amino Acid Agents trials Research Report on Excitatory Amino Acid Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg), Placebo - Suicide, Depressive Disorder, Treatment-Resistant
Phase 2RecruitingNational Institute of Mental Health (NIMH)502024-11-062026-10-05
Natural History of Depression, Bipolar Disorder and Suicide Risk
Behavioral Symptoms, Suicide
RecruitingNational Institute of Mental Health (NIMH)5002024-09-092026-11-03

Narrower conditions

Behavioral Symptoms (2)  ·  Depression (2)  ·  Depressive Disorder (2)  ·  Depressive Disorder, Major (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Suicide (2)  ·  Bipolar Disorder (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Self-Injurious Behavior (1)

Broader conditions

Behavior (2)  ·  Bipolar and Related Disorders (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Self-Injurious Behavior (1)

Interventions

6-hydroxynorketamine (1)

Sponsors

National Institute of Mental Health (NIMH) (2)

Countries

United States (2)

Top investigators

Carlos A Zarate, M.D. (1)  ·  Elizabeth D Ballard, Ph.D. (1)